Skip to content

Research on medical imaging analysis and application of artificial intelligence in thyroid nodules

Research on medical imaging analysis and application of artificial intelligence in thyroid nodules

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060823
Enrollment
Unknown
Registered
2022-06-12
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid tumor

Interventions

0:no

Sponsors

Ruijin hospital, Shanghai jiaotong university school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Over 18 years of age at diagnosis; 2.Preoperative puncture pathology showed thyroid tumor; 3.Receive elective thyroid operation; 4.Baseline clinical staging: CT0-4N0-2M0; 5.Patients and their family members can understand and are willing to participate in this clinical study, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with puncture pathology inconsistent with postoperative pathology; 2.Patients who have had thyroid surgery or other neck surgery before surgery; 3.Patients with severe preoperative tumor involvement of the nerve or trachea and associated symptoms; 4.Patients who had undergone preoperative ultrasound ablation for thyroid cancer; 5.Patients with distant metastases; 6.Patients who had participated in or were participating in another clinical trial within 4 weeks prior to enrollment; 7.Patients with ASA grade greater than grade III; 8.Physical Status: Patients with a card score less than 60 or an ECOG score greater than 2; 9.Patients with liver insufficiency; 10.Patients with a history of severe mental illness; 11.Pregnant or lactating women; 12.The investigator considered the patient to be unsuitable for participation in the study due to other condition.

Design outcomes

Primary

MeasureTime frame
tumor diameter;

Countries

CHINA

Contacts

Public ContactQiu Weihua

Ruijin hospital, Shanghai jiaotong university school of medicine

qwh11072@rjh.com.cn+86 18818270900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026